September 2025 - Page 24 of 28

ThursdaySep 04, 2025 3:10 pm

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Eyes ‘Value-Creation Strategy in Action’

Brera Holdings (NASDAQ: BREA) is an Ireland-based international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) strategy. The company recently announced that portfolio club SS Juve Stabia is preparing for the 2025/26 Serie B season with a revamped coaching staff and key player signings. “This follows a standout 2024/25 campaign that saw the team finish fifth in the table and reach the semifinals of the Serie A promotion playoffs, driving rising valuation,” reads a recent article. “Player moves also reflect an aggressive offseason strategy… These moves follow a notable increase…

ThursdaySep 04, 2025 2:10 pm

QualityStocksNewsBreaks – Why Wearable Devices Ltd. (NASDAQ: WLDS) Is ‘One to Watch’

Wearable Devices (NASDAQ: WLDS, WLDSW) is a technology company pioneering the next generation of human-computer interaction through AI-powered neural input wearables. “Mudra, its proprietary wrist-worn technology, enables touchless, gesture-based control of digital devices, offering users a seamless, intuitive interface through subtle finger and hand movements. Since introducing its technology to the market in 2014, the company has pursued both business-to-business (‘B2B’) and business-to-consumer (‘B2C’) strategies through a dual-channel model,” reads a recent article. “The company believes the future of technology should begin with the human. Wearable Devices envisions decoding the human body to enable context-aware AI-powered technology that listens, learns, and…

ThursdaySep 04, 2025 12:54 pm

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Publishes Data Demonstrating Two-Year Stability of ThermoVax Ebolavirus Vaccines

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced the publication of new data showing extended stability of its ebolavirus vaccines developed with the ThermoVax(R) platform. Bivalent and trivalent vaccines formulated from Zaire ebolavirus, Sudan ebolavirus, and Marburg marburgvirus antigens retained full potency after two years of storage at up to 40°C (104°F), according to a manuscript accepted by Vaccine. Developed in collaboration with Dr. Axel Lehrer at the University of Hawaiʻi at Mānoa, the thermostable vaccines have demonstrated robust immune responses in animal models, with up to 100% protection in non-human primates. Soligenix noted that…

ThursdaySep 04, 2025 12:41 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Presents Preclinical Data Showing CNM-Au8 Improves Cellular Health in Parkinson’s Disease Model

Clene (NASDAQ: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc., announced new preclinical data demonstrating that CNM-Au8(R) improved mitochondrial function, reduced inflammation, and restored cellular metabolism in a novel dopaminergic neuron model of Parkinson’s disease (PD). The findings, presented at the Michael J. Fox Foundation H2 Therapeutics Stewardship Meeting in New York City, showed CNM-Au8 corrected metabolic imbalances, normalized dysregulated gene expression, and exhibited a favorable safety profile with no toxicity observed in PD neurons. Conducted in collaboration with the Salk Institute and supported by MJFF funding, the study underscores CNM-Au8’s potential as a neuroprotective therapy for both…

ThursdaySep 04, 2025 12:00 pm

SuperCom Ltd. (NASDAQ: SPCB) Reports Record Income, Growing Profit in H1 2025 as U.S. Expansion Accelerates

H1 2025 revenue reached $14.2 million with net income up nearly 80% year-over-year. Gross margin expanded to 61.2% from 52.3% in the prior-year period. EBITDA rose 41% to $5.1 million, while operating margin more than doubled. Management sees continued momentum in the U.S. market, where the company secured over 30 new electronic monitoring (EM) contracts since mid-2024. Working capital improved to $40.8 million, with cash reserves of $15 million. SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, reported strong results for the second quarter and first half of 2025, with profitability and margins rising even…

ThursdaySep 04, 2025 11:15 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Advances RapidSX Technology to Revolutionize Rare Earth Processing

RapidSX is a patent-pending, column-based solvent extraction technology that offers a transformative leap over traditional methods. The Strategic Metals Complex in Alexandria, Louisiana, serves as the proving ground for RapidSX technology. Ucore's RapidSX technology has undergone rigorous testing and independent evaluations, consistently demonstrating superior performance. In the race to secure a sustainable and independent supply of rare earth elements (“REEs”), Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) stands at the forefront with its groundbreaking RapidSX(TM) technology. This innovative approach to REE separation promises to significantly enhance processing efficiency, reduce environmental impact and bolster the United States' position in the global rare…

ThursdaySep 04, 2025 11:05 am

QualityStocksNewsBreaks – A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Announces $55 Million Smart Cart Purchase Order with Yochananof

A2Z Cust2Mate Solutions (NASDAQ: AZ), a global smart retail technology company, announced a $55 million purchase order with Israeli supermarket chain M. Yochananof & Sons (1988) Ltd. for 5,000 Cust2Mate 3.0 smart shopping carts. The agreement includes an upfront payment and monthly fees per cart over at least 60 months, along with a data, retail media and digital services partnership. Deployment has begun and will continue monthly through 2026, with up to 250 units placed in large stores and 100 in medium-sized locations. A2Z will also repurchase Yochananof’s existing Gen 2.5 carts for $7 million as the new fleet rolls…

ThursdaySep 04, 2025 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Treatment with FDA Orphan Designation

The FDA’s orphan drug designation for dusquetide follows encouraging phase 2a clinical trial results demonstrating both biological efficacy and a favorable safety profile. CEO notes that “the FDA's decision to grant orphan drug designation to the SGX945 program signifies an important step for Soligenix.” Phase 2a pilot data demonstrated clinically meaningful improvements in oral aphthous ulcer healing. Soligenix (NASDAQ: SNGX) has taken a decisive step forward in the fight against rare diseases, announcing that the FDA has granted orphan drug designation to its investigational therapy dusquetide for the treatment of Behçet’s disease (https://ibn.fm/0t1aK). This key FDA designation underscores not only…

ThursdaySep 04, 2025 10:30 am

QualityStocksNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Launches Inventory Auction to Support Operational Optimization and Integration Expansion

Vision Marine Technologies (NASDAQ: VMAR), a provider of electric marine propulsion and multi-brand boat retail, announced plans to auction discontinued, overstocked, and clearance parts inventory from its Florida operations on Sept. 16-18, 2025, in partnership with Stampler Auctions. Expected to generate $1.3 million to $1.8 million, the initiative provides a non-dilutive capital boost while repurposing 5,000 square feet at Vision Marine’s Fort Lauderdale marina into an integration center and sales office with direct water access. The auction supports the company’s post-acquisition integration of Nautical Ventures and aligns with its strategy to expand service, financing, and electric integration programs, positioning its…

ThursdaySep 04, 2025 10:20 am

QualityStocksNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Achieves Debt-Free Status Ahead of Schedule

Beeline Holdings (NASDAQ: BLNE), a digital mortgage platform redefining the path to homeownership, announced it has paid down all outstanding debt, excluding warehouse lines used to fund mortgage transactions. The Company, which began 2025 with more than $7 million in debt, has now cleared all notes payable and secured credit facilities, including senior secured debentures, achieving debt-free status earlier than expected. With a strengthened balance sheet, Beeline is focused on accelerating growth and innovation, supported by cost optimization, new product launches, and revenue momentum. The Company expects to reach cash flow positive operations by Q1 2026. To view the full press…

Site Search

Company Search

Month: September 2025